|
2024
|
Invention
|
Monoclonal anti-ptk7 antibodies and derivatives. The present invention relates to a novel anti-PT... |
|
|
Invention
|
Alpha-emitting radionuclides for use in the treatment of peritoneal cancer. The present invention... |
|
2021
|
Invention
|
Size controlled radiolabelled particles.
The present disclosure relates to a particle comprising... |
|
|
Invention
|
Preparations of radium-224 and progenies for use in radionuclide therapy in combination with dna ... |
|
|
Invention
|
Size controlled radiolabelled particles. The present disclosure relates to a particle comprising ... |
|
2017
|
Invention
|
Anti-osteosarcoma car-t derived from the antibody oi-3.
The invention relates to chimeric antige... |
|
|
Invention
|
Anti-osteosarcoma car-t derived from the antibody oi-3. The invention relates to chimeric antigen... |
|
|
P/S
|
Pharmaceutical and veterinary preparations for the treatment of cancer; pharmaceutical and veteri... |
|
|
P/S
|
Pharmaceutical and veterinary preparations for the treatment of cancer and for suppressing tumour... |
|
|
P/S
|
Pharmaceutical and veterinary preparations for the treatment of cancer; sanitary preparations for... |
|
|
P/S
|
Scientific and technological services, namely, research and design in the field of cancer treatme... |
|
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary
preparations for medical purposes; dietetic... |
|
|
P/S
|
Pharmaceuticals and veterinary preparations; sanitary
preparations for medical purposes; dieteti... |
|
2016
|
Invention
|
Radiotherapeutic particles and suspensions. The present invention relates to a particle or pharma... |
|
2014
|
Invention
|
Monoclonal antibody and derivatives. The present invention relates to a novel anti-CD146 antibody... |
